DRKS00032606RecruitingNot Applicable
A cross-sectional study on HPV vaccination in German women undergoing excisional CIN therapy and the impact of reimbursement on the acceptance (HPV vacCINe study) - HPV vacCINe study
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- MSD Sharp & Dohme GmbH
- Enrollment
- 1,023
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- Female
Inclusion Criteria
- •Subject is scheduled for excisional therapy of CIN
- •Permanent coverage by a German statutory or private health insurance since at least one year
- •Signed informed consent form (ICF) including data protection consent and signed contact information sheet
Exclusion Criteria
- •Subject is not able to read and understand the questionnaires and other study documents (ICF etc.) in German or English language
- •Subject is pregnant during the enrollment period
- •Subject is not willing to provide contact information
- •Subject does not have technical means to complete an electronic questionnaire
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of the effect of quaternary HPV vaccine in the treatment of women with cervical intraepithelial neoplasia cin1Evaluation of the effect of quaternary HPV vaccine in the treatment of women with cervical intraepithelial neoplasia cin1 of Fatemiye Hospitan, Hamadan.IRCT20230522058253N2Hamedan University of Medical Sciences300
Recruiting
Phase 3
VAC-WARTS2024-513671-40-00Assistance Publique Hopitaux De Paris146
Recruiting
Not Applicable
Study of the efficacy of HPV vaccination against cervical cancerCervical cancerJPRN-UMIN000026769Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Science8,000
Active, not recruiting
Phase 1
VAC-WARTSHPV vaccineCTIS2024-513671-40-00Assistance Publique Hopitaux De Paris146
Active, not recruiting
Phase 1
VulVaccin studyVulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)CTIS2023-506792-94-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)498
